Regulatory Q&A Forum
Ask questions, share knowledge, and get help from the regulatory community
When planning for European market entry, non-EU medical device manufacturers often focus on commercial logistics, including the appointment of a VAT Fiscal Representative. However, a distinct and crit...
For medical device manufacturers placing products on the EU market, compliance with the Waste Electrical and Electronic Equipment (WEEE) Directive and national Extended Producer Responsibility (EPR) l...
With significant updates to the EU's Waste Electrical and Electronic Equipment (WEEE) Directive anticipated around 2026, how should medical device manufacturers strategically evaluate and select an EU...
While manufacturers often ask for a single price for a WEEE/EPR Representative in Germany, the cost is not a flat fee but is influenced by several key factors. What are the primary variables that dete...
When a major international standard for the biological evaluation of medical devices is updated, how should manufacturers strategically revise their biocompatibility testing programs for both new and ...
With significant updates to international biocompatibility consensus standards anticipated, how should medical device manufacturers strategically evaluate and select a testing partner to ensure future...
When preparing a 510(k) submission, what does a comprehensive biocompatibility evaluation involve beyond simply selecting tests from a standard? While it is understood that medical devices with direc...
As the UK's post-Brexit medical device regulatory framework continues to evolve towards a new system, non-UK manufacturers face the critical task of ensuring their UK Responsible Person (UKRP) is prep...
For non-UK medical device manufacturers planning for market access, securing a UK Responsible Person (UKRP) is a critical compliance step. As regulatory frameworks evolve, budgeting for this service b...
When non-UK based medical device manufacturers seek to place products on the Great Britain market (England, Wales, and Scotland), they must appoint a UK Responsible Person (UKRP). While the cost of UK...
For sponsors developing a novel pharmacogenetic assessment system, what are the key regulatory hurdles and evidence requirements under 21 CFR 862.3364? This regulation identifies such a device as a qu...
For manufacturers of Class II in vitro diagnostic (IVD) devices, how do the foundational regulations, device-specific special controls, and associated FDA guidance documents interact to form the compl...
As global Extended Producer Responsibility (EPR) and Waste from Electrical and Electronic Equipment (WEEE) regulations become more complex, particularly with ongoing discussions around potential revis...
Given the significant revisions to the EU WEEE Directive anticipated around 2026, how can a medical device manufacturer move beyond basic compliance and strategically select a Producer Responsibility ...
How can a medical device manufacturer effectively evaluate a biocompatibility testing laboratory's readiness for significant upcoming updates to international standards like ISO 10993? Selecting a par...
Given the anticipated updates to the ISO 10993 series of standards, how should medical device manufacturers strategically evaluate and select a contract research organization (CRO) for biocompatibilit...
With the UK medical device regulatory landscape continuing to evolve ahead of significant expected changes, non-UK manufacturers face the critical task of appointing a UK Responsible Person (UKRP). Be...
With the UK's regulatory landscape for medical devices continuing to evolve, non-UK manufacturers face the critical task of appointing a UK Responsible Person (UKRP) to ensure market access and compli...
What key criteria and due diligence steps should a non-EU medical device manufacturer implement when selecting an EU Authorised Representative (AR) to ensure long-term compliance with the Medical Devi...
As the EU cosmetics landscape prepares for significant regulatory updates anticipated around 2026, including potential new ingredient restrictions and revised labeling rules, how should a non-EU brand...